Search Results

You are looking at 1 - 1 of 1 items for

  • Author: Hao-Jie Zhu x
  • Refine by access: All content x
Clear All Modify Search
Shou-Si Lu
Search for other papers by Shou-Si Lu in
Google Scholar
PubMed
Close
,
Yun-Li Yu
Search for other papers by Yun-Li Yu in
Google Scholar
PubMed
Close
,
Hao-Jie Zhu Key Lab of Drug Metabolism and Pharmacokinetics, Department of Pharmaceutical and Biomedical Science, China Pharmaceutical University, Nanjing 210009, People's Republic of China

Search for other papers by Hao-Jie Zhu in
Google Scholar
PubMed
Close
,
Xiao-Dong Liu
Search for other papers by Xiao-Dong Liu in
Google Scholar
PubMed
Close
,
Li Liu
Search for other papers by Li Liu in
Google Scholar
PubMed
Close
,
Yao-Wu Liu
Search for other papers by Yao-Wu Liu in
Google Scholar
PubMed
Close
,
Ping Wang
Search for other papers by Ping Wang in
Google Scholar
PubMed
Close
,
Lin Xie
Search for other papers by Lin Xie in
Google Scholar
PubMed
Close
, and
Guang-Ji Wang
Search for other papers by Guang-Ji Wang in
Google Scholar
PubMed
Close

Berberine (BBR), a hypoglycemic agent, has shown beneficial metabolic effects for anti-diabetes, but its precise mechanism was unclear. Glucagon-like peptide-1 (GLP-1) is considered to be an important incretin that can decrease hyperglycemia in the gastrointestinal tract after meals. The aim of this study was to investigate whether BBR exerts its anti-diabetic effects via modulating GCG secretion. Diabetes-like rats induced by streptozotocin received BBR (120 mg/kg per day, i.g) for 5 weeks. Two hours following the last dose, the rats were anaesthetized and received 2.5 g/kg glucose by gavage. At 15-minute and 30-minute after glucose load, blood samples, pancreas, and intestines were obtained to measure insulin and GCG using ELISA kit. The number of L cells in the ileum and β-cells in the pancreas were identified using immunohistology. The expression of proglucagon mRNA in the ileum was measured by RT-PCR. The results indicated that BBR treatment significantly increased GCG levels in plasma and intestine (P<0.05) accompanied with the increase of proglucagon mRNA expression and the number of L-cell compared with the controls (P<0.05). Furthermore, BBR increased insulin levels in plasma and pancreas as well as β-cell number in pancreas. The data support the hypothesis that the anti-diabetic effects of BBR may partly result from enhancing GCG secretion.

Free access